Chemical Diversity of Metabolites from Fungi, Cyanobacteria, and Plants Relative to FDA-Approved Anticancer Agents. - sprookjes - yvandenbroek - TriplyDB

Chemical Diversity of Metabolites from Fungi, Cyanobacteria, and Plants Relative to FDA-Approved Anticancer Agents.

Chemical Diversity of Metabolites from Fungi, Cyanobacteria, and Plants Relative to FDA-Approved Anticancer Agents.

http://www.wikidata.org/entity/Q36237762

about

Discovery of Anticancer Agents of Diverse Natural Origin Dereplicating and Spatial Mapping of Secondary Metabolites from Fungal Cultures in Situ.Greensporones: resorcylic acid lactones from an aquatic Halenospora sp.Enhanced dereplication of fungal cultures via use of mass defect filtering.Polyhydroxyanthraquinones as quorum sensing inhibitors from the guttates of Penicillium restrictum and their analysis by desorption electrospray ionization mass spectrometry.Investigation of Vietnamese plants for potential anticancer agents.Biosynthetically Distinct Cytotoxic Polyketides from Setophoma terrestris.Sorbicillinoid analogs with cytotoxic and selective anti-Aspergillus activities from Scytalidium album Spiroscytalin, a new tetramic acid and other metabolites of mixed biogenesis from Scytalidium cuboideum.Scaffold Diversity of Fungal Metabolites Benzoquinones and terphenyl compounds as phosphodiesterase-4B inhibitors from a fungus of the order Chaetothyriales (MSX 47445).Waol A, trans-dihydrowaol A, and cis-dihydrowaol A: polyketide-derived γ-lactones from a Volutella species.High-resolution MS, MS/MS, and UV database of fungal secondary metabolites as a dereplication protocol for bioactive natural products.PDTCM: a systems pharmacology platform of traditional Chinese medicine for psoriasis.Chemoinformatic expedition of the chemical space of fungal products Texas Native Plants Yield Compounds with Cytotoxic Activities against Prostate Cancer Cells.Evaluation of culture media for the production of secondary metabolites in a natural products screening program.Structural Elucidation and Molecular Docking of a Novel Antibiotic Compound from Cyanobacterium Nostoc sp. MGL001.The Combined Use of in Silico, in Vitro, and in Vivo Analyses to Assess Anti-cancerous Potential of a Bioactive Compound from Cyanobacterium Nostoc sp. MGL001.Developments of Cyanobacteria for Nano-Marine Drugs: Relevance of Nanoformulations in Cancer Therapies.The impact of culture conditions on growth and metabolomic profiles of freshwater cyanobacteria Chemoselective fluorination and chemoinformatic analysis of griseofulvin: Natural vs fluorinated fungal metabolites

P2860

Q28068341-997DC265-E03D-4C15-8169-8BB02D4C0680 Q30664541-DE804381-8C32-45DA-BE06-A3E5F615B6B7 Q30840705-54F4269E-CB5C-4741-8B26-552683DF43CB Q33611257-C89F2F9A-25F7-4205-8791-0C797EF4DAC5 Q33815668-AECF3C02-5993-404D-8E4D-F8A36EF4BAE6 Q34478640-E2459224-19F1-4F46-8514-2BD289284A9C Q34820959-27EEE4C8-00FF-4EA8-A3D6-154E8EA192EA Q35214188-518358D3-F0E3-4663-A1ED-EDC7509F5ECC Q36218793-B04830EF-3191-44B0-9DB4-091E0A2B9082 Q36350419-CC364DC5-3CB0-4FA8-8677-13803CD4EC0E Q36711252-D8101151-1B55-47DF-994D-DCBC2C0561FD Q37095603-CF5A51F0-DAB1-4B07-A3B7-821AF6D288CA Q37375876-F16E60C5-1193-408A-927E-E95120780EA2 Q38637309-7B99A3B5-61A4-42C7-9654-B2C1B1118F84 Q38835061-C3A32886-876E-4F1E-AF50-D736ACBA4CED Q41186415-26A93978-8F68-48C4-B125-2396A893BC8B Q41931485-6C7174F9-7DF7-4B12-9DC5-CF1E9E1835AD Q42362560-4301F708-1D64-4A55-8CAE-2187E78F2F2B Q47141331-0B6C5BEE-8569-4D62-81A2-70F5C2744490 Q55453641-974BEE7D-36BA-4920-A251-13767B7C368C Q57193150-69A1BD6F-CB1B-41C2-9427-396AADFAD056 Q57268361-CE403533-DDF3-45C9-8F6E-E65644545781

P2860

Chemical Diversity of Metabolites from Fungi, Cyanobacteria, and Plants Relative to FDA-Approved Anticancer Agents.

http://www.wikidata.org/entity/Q36237762

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Chemical Diversity of Metaboli ...... DA-Approved Anticancer Agents.

@ast

Chemical Diversity of Metaboli ...... DA-Approved Anticancer Agents.

@en

type

label

Chemical Diversity of Metaboli ...... DA-Approved Anticancer Agents.

@ast

Chemical Diversity of Metaboli ...... DA-Approved Anticancer Agents.

@en

prefLabel

Chemical Diversity of Metaboli ...... DA-Approved Anticancer Agents.

@ast

Chemical Diversity of Metaboli ...... DA-Approved Anticancer Agents.

@en

P1433

Q36237762-85C3F293-27DD-4606-BF82-75C7A85714C8

P1476

Q36237762-6E35F1DF-3F44-4510-8594-882DA3E81089

P2093

Q36237762-3FB9813C-95AE-42D3-B292-75855C58CFFD

Q36237762-44A2BB6B-5D6C-43CD-BDE0-BC8338E307AD

Q36237762-6CBD83FD-804F-4262-A54E-7003B4A3ECC3

Q36237762-8AD29D2D-117D-45ED-A5D0-D7F1F71B0512

Q36237762-CFCA3380-E837-41AC-A377-4E0D4C51575E

Q36237762-E97CC906-9074-4FCC-BC0C-E32A3276E324

P2860

Q36237762-004030B6-CF7C-4AA1-A45F-EA5837708990

Q36237762-0F888E7C-E463-49B8-A748-FE1677481B81

Q36237762-1084869E-D4FF-425F-87B4-DB2FFE8FB056

Q36237762-1F20E290-0490-4162-9EAE-8DF112807E62

Q36237762-3B3D1381-B4CA-482F-8605-3BE8294C639A

Q36237762-4F889654-938C-4037-AFAF-19096FAC6A13

Q36237762-96587B60-120D-4CCC-BCE2-CC0D5E7517EF

Q36237762-9C14DDCE-D3A0-4E4E-9588-DAABA2642580

Q36237762-AFE75139-7197-48B0-8BE8-97EC6976DDC3

Q36237762-B5339C28-3C2F-41C3-BED7-3C12E6710126

P304

Q36237762-81B2B216-3567-4EEF-8CAF-91AB2CD73644

P31

Q36237762-BD6CAF79-2310-477C-B6A0-E39A7C23DF7C

P356

Q36237762-A1B11A5B-91EF-4806-A8AD-137DF77C4FCC

P433

Q36237762-6CF6D32B-D3A6-41BD-8492-E5941F835203

P478

Q36237762-899753CE-C0C7-44AF-9F12-30539825C3FE

P50

Q36237762-5376D47D-DB4D-4EDF-908A-C1ABB479A770

Q36237762-65981AC8-588E-4F12-9594-BD8BBABAFE79

P577

Q36237762-09C45557-E0D7-40F3-940B-B8A7E026BF03

P5875

Q36237762-1457C53B-C3BF-40DD-B36E-07BABD6B420C

P698

Q36237762-3E4F5281-A7B5-4F6A-A137-EA5F3E056D57

P921

Q36237762-641D82CF-F83E-428D-ADD5-334318504320

P932

Q36237762-3BCF6998-EA77-4043-907F-3F701525C87B

P356

P1433

ACS Medicinal Chemistry Letters

P1476

Chemical Diversity of Metaboli ...... FDA-Approved Anticancer Agents

@en

P2093

Cedric J Pearce

http://www.w3.org/2001/XMLSchema#string

David Jarjoura

http://www.w3.org/2001/XMLSchema#string

Franklin J Moy

http://www.w3.org/2001/XMLSchema#string

Jimmy Orjala

http://www.w3.org/2001/XMLSchema#string

Tamam El-Elimat

http://www.w3.org/2001/XMLSchema#string

Xiaoli Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B

Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties

Natural products as sources of new drugs over the 30 years from 1981 to 2010

Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries.

Diversity-oriented synthesis: exploring the intersections between chemistry and biology.

Chemoinformatic analysis of combinatorial libraries, drugs, natural products, and molecular libraries small molecule repository.

Thielavin B methyl ester: a cytotoxic benzoate trimer from an unidentified fungus (MSX 55526) from the Order Sordariales

Resorcylic acid lactones with cytotoxic and NF-κB inhibitory activities and their structure-activity relationships

Obionin B: An o-pyranonaphthoquinone decaketide from an unidentified fungus (MSX 63619) from the Order Pleosporales

P304

645-649

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ML300105S

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas H. Oberlies

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230885457

http://www.w3.org/2001/XMLSchema#string

P698

22993669

http://www.w3.org/2001/XMLSchema#string

P921

P932

3443637

http://www.w3.org/2001/XMLSchema#string